Notice: Function _load_textdomain_just_in_time was called incorrectly. Translation loading for the wordpress-seo domain was triggered too early. This is usually an indicator for some code in the plugin or theme running too early. Translations should be loaded at the init action or later. Please see Debugging in WordPress for more information. (This message was added in version 6.7.0.) in /var/www/html/wp-includes/functions.php on line 6260 Vetter Expands PFS Services | Contract Pharma

What are you searching for?

Sign in
Breaking News

Vetter Expands PFS Services

New Ravensburg line to handle one million prefilled syringes a day

By: Gil Roth

President, Pharma & Biopharma Outsourcing Association

Vetter is building a high-performance filling line for syringes at its Ravensburg Vetter South location. The new line can handle batches of as much as 1 million units per day and is well suited for the aseptic filling of high-volume products, like vaccines, according to the company.

The company is also expanding its services for the early clinical phases of new drugs. At its Vetter Development Service locations in Chicago and Ravensburg, the company offers a range of services including formulation support and customized packaging development. With another new filling line at the Ravensburg facility and further investments planned in Chicago, Vetter continues to increase its capabilities in clinical manufacturing.

“Vetter is continuously and strategically investing in its partnerships with international customers,” said Peter Soelkner, Vetter Managing Director. “In the area of prefilled syringes, we provide our partners a full range of service, from small batches manufacturing and support in early clinical stages to high-volume manufacturing for large scale commercial production.”

Add us as a preferred source on Google

Get the latest Contract Pharma news, insights and analysis in your Google Search and AI experiences.

Add Contract Pharma as a preferred source on Google (opens in a new tab)

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters

Topics